Loading clinical trials...
Loading clinical trials...
Central serous chorioretinopathy (CSC) has been known since it was first described by Von Graefe and termed "idiopathic detachment of the macula" in 1866, is a well-characterized disorder leading to s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asociación para Evitar la Ceguera en México
NCT07347119 · Central Serous Chorioretinopathy (CSC)
NCT05686421 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more
NCT05633576 · Chronic Central Serous Chorioretinopathy
NCT05847049 · Central Serous Chorioretinopathy
NCT02088151 · Macular Edema, Central Serous Chorioretinopathy, and more
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions